Results 71 to 80 of about 966,359 (290)

Clostridium difficile Infection, Colorado and the Northwestern United States, 2007

open access: yesEmerging Infectious Diseases, 2012
To determine the incidence of Clostridium difficile infection during 2007, we examined infection in adult inpatient and outpatient members of a managed-care organization. Incidence was 14.9 C. difficile infections per 10,000 patient-years.
Jennifer L. Kuntz   +8 more
doaj   +1 more source

Targeting B‐Cell‐Activating Factor and Its Receptor in Immune Thrombocytopenia and Warm Autoimmune Hemolytic Anemia

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Current treatments for immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA), rare autoimmune diseases in which autoreactive B cells play a major role, can lead to high response rates; however, for many patients these responses are not durable or maintained after treatment discontinuation.
Matthieu Mahévas   +4 more
wiley   +1 more source

Reducing the Risk of Severe Complications among Patients with Clostridium difficile Infection

open access: yesCanadian Journal of Gastroenterology, 2011
BACKGROUND: The incidence and severity of Clostridium difficile infections are increasing, and there is a need to optimize the prevention of complicated disease.
Kamran Manek   +3 more
doaj   +1 more source

Clostridium septicum sepsis and colorectal cancer - a reminder

open access: yesWorld Journal of Surgical Oncology, 2009
Background Spontaneous clostridium septicum infections are rare and are associated with a high mortality. Association of clostridium infection with colorectal malignancies have been previously reported and most cases are described in tumours of the ...
McCloud Jonathon M   +2 more
doaj   +1 more source

How do hospital professionals involved in a randomised controlled trial perceive the value of genotyping vs. PCR-ribotyping for control of hospital acquired C. difficile infections? [PDF]

open access: yes, 2014
Background: Despite scientific advances in typing of C. difficile strains very little is known about how hospital staff use typing results during periods of increased incidence (PIIs). This qualitative study, undertaken alongside a randomised controlled
Peter M Hawkey   +16 more
core   +2 more sources

Microbial‐Metabolite Signatures Are Associated With Glucocorticoid Responsiveness in Chronic Rhinosinusitis With Nasal Polyps

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) exhibit heterogeneous responses to oral glucocorticoids (GCs), but the biological basis of this variability remains unclear. Objective To identify gut microbiome‒plasma metabolomic signatures associated with GC responsiveness in CRSwNP patients and to compare their ...
Ying‐Ying Zhang   +7 more
wiley   +1 more source

Clostridium species diversity in cattle

open access: yesВетеринария сегодня
Introduction. Clostridial infections, though relatively sporadic, are globally ubiquitous and specified by high mortality rates, resulting in substantial economic losses to agriculture.
P. N. Shastin   +5 more
doaj   +1 more source

Clinical Risk Factors for Severe Clostridium difficile–associated Disease

open access: yesEmerging Infectious Diseases, 2009
Identifying patients who are at high risk for severe Clostridium difficile–associated disease (CDAD) early in the course of their infection may help clinicians improve outcomes.
Timothy J. Henrich   +3 more
doaj   +1 more source

Point of care tests for hospital-acquired infections (HAIs) : economic analysis report [PDF]

open access: yes
A number of clinical/disease areas have been prioritised by the Technology Strategy Board (TSB) and Department of Health (DH) for the DIIA Innovation Platform.
Szczepura, Ala, Osipenko, Leeza
core  

Rewriting Tumor Immunity With Bacterial Membrane Vesicles: A Versatile and Potent Therapeutic Strategy

open access: yesAdvanced NanoBiomed Research, EarlyView.
Bacterial membrane vesicles (BMVs) emerge as promising platforms for cancer immunotherapy owing to their intrinsic adjuvant properties and tunable cargo delivery capabilities. Their ability to modulate the tumor microenvironment, enhance antitumor immune responses, and support personalized therapeutic strategies highlights their growing potential as ...
Md Sifat Rahi   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy